中文 | English
Return
Total: 142 , 1/15
Show Home Prev Next End page: GO
MeSH:(Capecitabine*)

4.Hand-foot Syndrome Due to Capecitabine.

Chong Won CHOI ; Chang Hun HUH

Korean Journal of Dermatology 2005;43(7):965-968

6.XELOX ± Bevacizumab compared to FOLFOX4 ± Bevacizumab in first line metastatic colorectal cancer in a non-reimbursed health care system: A cost analysis.

Tan Jerry Y. ; Yacat Andrew A ; Sacdalan Dennis L.

Acta Medica Philippina 2015;49(2):64-67

7.Pathologic Complete Remission after Preoperative Chemoradiation for Rectal Cancer: Analysis of Clinicopathologic Characteristics and Oncologic Outcome.

Dae Dong KIM ; Chang Sik YU ; Ui Sup SHIN ; Sang Nam YOON ; Jin Cheon KIM

Journal of the Korean Society of Coloproctology 2008;24(6):473-478

8.A Phase II Study of Additional Four-Week Chemotherapy With Capecitabine During the Resting Periods After Six-Week Neoadjuvant Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer.

Kyung Ha LEE ; Min Sang SONG ; Jun Boem PARK ; Jin Soo KIM ; Dae Young KANG ; Ji Yeon KIM

Annals of Coloproctology 2013;29(5):192-197

9.A Phase II Study of Additional Four-Week Chemotherapy With Capecitabine During the Resting Periods After Six-Week Neoadjuvant Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer.

Kyung Ha LEE ; Min Sang SONG ; Jun Boem PARK ; Jin Soo KIM ; Dae Young KANG ; Ji Yeon KIM

Annals of Coloproctology 2013;29(5):192-197

10.Overview of Radiation Therapy for Treating Rectal Cancer.

Bong Hyeon KYE ; Hyeon Min CHO

Annals of Coloproctology 2014;30(4):165-174

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 142 , 1/15 Show Home Prev Next End page: GO